Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Regadenoson manufacturers

1 products found

Filters

1 products found

regadenoson

Injection, pre-filled syringe 0.4 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP
Unavailable markets
Peru
Available for
Licensing with supply, Distribution only
Manufacturer #16394

Manufacturer usually replies in 12 days

REGADENOSON Manufacturers

Regadenoson is a coronary vasodilator commonly used in radionuclide myocardial perfusion imaging (MPI). This pharmaceutical drug is an A2A adenosine receptor agonist that causes coronary vasodilation and is practiced for myocardial perfusion imagining. Created by Astellas and FDA approved back on April 10, 2008. Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking this medicine: You should not use REGADENOSONif you are allergic to it REGADENOSON may also is used for purposes that may not have been listed in this medication guide.

How does REGADENOSON Work?

Read the REGADENOSON Guide and, if available, the Patient Information Leaflet that will be provided by your pharmacist before you start taking REGADENOSON. If you have any questions related to REGADENOSON, ask your pharmacist or doctor. This medical substance is a selective low-affinity (Ki= 1.3 µM) A2A receptor agonist that imitates the consequences of adenosine in causing coronary vasodilatation and developing myocardial blood flow. REGADENOSON is a very weak agonist of the A1 adenosine receptor (Ki > 16.5 µM). Moreover, this medical drug has a negligible affinity to A2B and A3 adenosine receptors. This medical remedy is undergoing trials for use in pharmacological stress tests.

How much money does REGADENOSON cost?

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the price. The cost for REGADENOSON 5mg is around USD 107. Prices may vary on the pharmacy you visit.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of REGADENOSON offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for REGADENOSON manufacturers and REGADENOSON suppliers that you are looking for. These also enable you to check the dossier status of REGADENOSON, and the GMP approvals of the different variants of REGADENOSON. Also, each manufacturer or supplier product description contains essential information about REGADENOSON including clinical data, stability zones, countries where REGADENOSON is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ivermectin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Ivermectin manufacturers have, we qualify their companies before they are onboarded on the platform. This allows us to screen Ivermectin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.